New brain scan reveals hidden clues in early Parkinson's
NCT ID NCT04735172
First seen Feb 28, 2026 · Last updated May 23, 2026 · Updated 15 times
Summary
This study uses a powerful 7T MRI scanner to measure brain chemicals in people newly diagnosed with Parkinson's who have not yet started medication. Researchers will compare these measurements to those from healthy volunteers to better understand how the disease affects brain metabolism. The goal is to find early markers of Parkinson's, which could lead to better treatments in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Poitiers
RECRUITINGPoitiers, France
Contact
-
Chu Clermont Ferrand
NOT_YET_RECRUITINGClermont-Ferrand, 63003, France
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.